These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 9824267)

  • 1. Targeting of sugar- and charge-modified albumins to fibrotic rat livers: the accessibility of hepatic cells after chronic bile duct ligation.
    Beljaars L; Poelstra K; Molema G; Meijer DK
    J Hepatol; 1998 Oct; 29(4):579-88. PubMed ID: 9824267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Albumin modified with mannose 6-phosphate: A potential carrier for selective delivery of antifibrotic drugs to rat and human hepatic stellate cells.
    Beljaars L; Molema G; Weert B; Bonnema H; Olinga P; Groothuis GM; Meijer DK; Poelstra K
    Hepatology; 1999 May; 29(5):1486-93. PubMed ID: 10216133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disease-induced drug targeting using novel peptide-ligand albumins.
    Meijer DK; Beljaars L; Molema G; Poelstra K
    J Control Release; 2001 May; 72(1-3):157-64. PubMed ID: 11389994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic and intrahepatic targeting of an anti-inflammatory agent with human serum albumin and neoglycoproteins as carrier molecules.
    Franssen EJ; Jansen RW; Vaalburg M; Meijer DK
    Biochem Pharmacol; 1993 Mar; 45(6):1215-26. PubMed ID: 8466542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of a new bioactive lipid-based drug carrier on cultured hepatic stellate cells and liver fibrosis in bile duct-ligated rats.
    Adrian JE; Poelstra K; Scherphof GL; Meijer DK; van Loenen-Weemaes AM; Reker-Smit C; Morselt HW; Zwiers P; Kamps JA
    J Pharmacol Exp Ther; 2007 May; 321(2):536-43. PubMed ID: 17314198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of chronic bile duct obstruction and LPS upon targeting of naproxen to the liver using naproxen-albumin conjugate.
    Albrecht C; Melgert BN; Reichen J; Poelstra K; Meijer DK
    J Drug Target; 1998; 6(2):105-17. PubMed ID: 9886235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting dexamethasone to Kupffer cells: effects on liver inflammation and fibrosis in rats.
    Melgert BN; Olinga P; Van Der Laan JM; Weert B; Cho J; Schuppan D; Groothuis GM; Meijer DK; Poelstra K
    Hepatology; 2001 Oct; 34(4 Pt 1):719-28. PubMed ID: 11584368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic endocytosis of various types of mannose-terminated albumins. What is important, sugar recognition, net charge, or the combination of these features.
    Jansen RW; Molema G; Ching TL; Oosting R; Harms G; Moolenaar F; Hardonk MJ; Meijer DK
    J Biol Chem; 1991 Feb; 266(5):3343-8. PubMed ID: 1993707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting 15d-prostaglandin J2 to hepatic stellate cells: two options evaluated.
    Hagens WI; Mattos A; Greupink R; de Jager-Krikken A; Reker-Smit C; van Loenen-Weemaes A; Gouw IA; Poelstra K; Beljaars L
    Pharm Res; 2007 Mar; 24(3):566-74. PubMed ID: 17245650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics of the hepatic stellate cell-selective carrier mannose 6-phosphate modified albumin (M6P(28)-HSA).
    Beljaars L; Olinga P; Molema G; de Bleser P; Geerts A; Groothuis GM; Meijer DK; Poelstra K
    Liver; 2001 Oct; 21(5):320-8. PubMed ID: 11589768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dexamethasone coupled to albumin is selectively taken up by rat nonparenchymal liver cells and attenuates LPS-induced activation of hepatic cells.
    Melgert BN; Olinga P; Jack VK; Molema G; Meijer DK; Poelstra K
    J Hepatol; 2000 Apr; 32(4):603-11. PubMed ID: 10782909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful targeting to rat hepatic stellate cells using albumin modified with cyclic peptides that recognize the collagen type VI receptor.
    Beljaars L; Molema G; Schuppan D; Geerts A; De Bleser PJ; Weert B; Meijer DK; Poelstra K
    J Biol Chem; 2000 Apr; 275(17):12743-51. PubMed ID: 10777570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The antiproliferative drug doxorubicin inhibits liver fibrosis in bile duct-ligated rats and can be selectively delivered to hepatic stellate cells in vivo.
    Greupink R; Bakker HI; Bouma W; Reker-Smit C; Meijer DK; Beljaars L; Poelstra K
    J Pharmacol Exp Ther; 2006 May; 317(2):514-21. PubMed ID: 16439617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The anti-fibrotic effect of liver growth factor is associated with decreased intrahepatic levels of matrix metalloproteinases 2 and 9 and transforming growth factor beta 1 in bile duct-ligated rats.
    Díaz-Gil JJ; García-Monzón C; Rúa C; Martín-Sanz P; Cereceda RM; Miquilena-Colina ME; Machín C; Fernández-Martínez A; García-Cañero R
    Histol Histopathol; 2008 May; 23(5):583-91. PubMed ID: 18283643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pharmacokinetic and biological activity profile of dexamethasone targeted to sinusoidal endothelial and Kupffer cells.
    Melgert BN; Weert B; Schellekens H; Meijer DK; Poelstra K
    J Drug Target; 2003 Jan; 11(1):1-10. PubMed ID: 12852435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Doxorubicin coupled to lactosaminated albumin: Effects on rats with liver fibrosis and cirrhosis.
    Di Stefano G; Fiume L; Domenicali M; Busi C; Chieco P; Kratz F; Lanza M; Mattioli A; Pariali M; Bernardi M
    Dig Liver Dis; 2006 Jun; 38(6):404-8. PubMed ID: 16595196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel lipid-based drug carrier targeted to the non-parenchymal cells, including hepatic stellate cells, in the fibrotic livers of bile duct ligated rats.
    Adrian JE; Kamps JA; Scherphof GL; Meijer DK; van Loenen-Weemaes AM; Reker-Smit C; Terpstra P; Poelstra K
    Biochim Biophys Acta; 2007 Jun; 1768(6):1430-9. PubMed ID: 17493581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting of naproxen covalently linked to HSA to sinusoidal cell types of the liver.
    Melgert BN; Wartna E; Lebbe C; Albrecht C; Molema G; Poelstra K; Reichen J; Meijer DK
    J Drug Target; 1998; 5(5):329-42. PubMed ID: 9771615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Massive targeting of liposomes, surface-modified with anionized albumins, to hepatic endothelial cells.
    Kamps JA; Morselt HW; Swart PJ; Meijer DK; Scherphof GL
    Proc Natl Acad Sci U S A; 1997 Oct; 94(21):11681-5. PubMed ID: 9326670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Local inhibition of liver fibrosis by specific delivery of a platelet-derived growth factor kinase inhibitor to hepatic stellate cells.
    Gonzalo T; Beljaars L; van de Bovenkamp M; Temming K; van Loenen AM; Reker-Smit C; Meijer DK; Lacombe M; Opdam F; Kéri G; Orfi L; Poelstra K; Kok RJ
    J Pharmacol Exp Ther; 2007 Jun; 321(3):856-65. PubMed ID: 17369283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.